Abstract
Fetal hemoglobin (Hb F) may increase in patients receiving chemotherapeutic drugs, a result of potential use in patients with symptomatic hemoglobinopathies. We examined Hb F in 13 patients with myeloproliferative disease (six polycythemia vera, five polycythemia vera with myeloid metaplasia, one agnogenic myeloid metaplasia, and one chronic myelogenous leukemia) who were treated with hydroxyurea. Four patients showed an increased in Hb F from 8% while on hydroxyurea, and a decline to
| Original language | English (US) |
|---|---|
| Pages (from-to) | 373-379 |
| Number of pages | 7 |
| Journal | Blood |
| Volume | 66 |
| Issue number | 2 |
| State | Published - 1985 |
| Externally published | Yes |
ASJC Scopus subject areas
- Hematology